当前位置:科学网首页 > 小柯机器人 >详情
新方法实现抗原特异性CD8+ T细胞的高通量和高维度单细胞分析
作者:小柯机器人 发布时间:2021/11/26 15:42:59

美国德克萨斯大学奥斯汀分校Ning Jiang小组实现抗原特异性CD8T细胞的高通量和高维度单细胞分析。这一研究成果于2021年11月22日在线发表在国际学术期刊《自然—免疫学》上。

研究人员报道了一种高维的、与四聚体相关的T细胞抗原受体(TCR)测序(TetTCR-SeqHD)方法,其可同时对数万个单细胞的同源抗原特异性、TCR序列、目标基因表达和表面蛋白表达进行分析。使用具有已知抗原特异性和TCR序列的人类多克隆CD8T细胞,研究人员证明了检测正确抗原特异性的精确度超过98%。研究人员还评估了抗原特异性CD8T细胞的基因表达和表型差异,并描述了流感和Epstein-Barr病毒特异性CD8T细胞的表型特征,这些特征对其病原体靶标是独一无二的。
 
此外,由于具有同时分析数百种抗原的高通量能力,研究人员应用TetTCR-SeqHD来鉴别了1型糖尿病患者与健康对照组相比优先富集于同源CD8+ T细胞的抗原,并发现一种与糖尿病相关和微生物组抗原交叉反应的TCR。TetTCR-SeqHD是剖析人类和小鼠T细胞反应的一种强大方法。
 
据介绍,尽管抗原特异性对T细胞功能至关重要,但由于技术上的难度,在基于多组学的高通量T细胞分析中常常被省略。
 
附:英文原文

Title: High-throughput and high-dimensional single-cell analysis of antigen-specific CD8+ T cells

Author: Ma, Ke-Yue, Schonnesen, Alexandra A., He, Chenfeng, Xia, Amanda Y., Sun, Eric, Chen, Eunise, Sebastian, Katherine R., Guo, Yu-Wan, Balderas, Robert, Kulkarni-Date, Mrinalini, Jiang, Ning

Issue&Volume: 2021-11-22

Abstract: Although critical to T cell function, antigen specificity is often omitted in high-throughput multiomics-based T cell profiling due to technical challenges. We describe a high-dimensional, tetramer-associated T cell antigen receptor (TCR) sequencing (TetTCR-SeqHD) method to simultaneously profile cognate antigen specificities, TCR sequences, targeted gene expression and surface-protein expression from tens of thousands of single cells. Using human polyclonal CD8+ T cells with known antigen specificity and TCR sequences, we demonstrate over 98% precision for detecting the correct antigen specificity. We also evaluate gene expression and phenotypic differences among antigen-specific CD8+ T cells and characterize phenotype signatures of influenza- and Epstein–Barr virus-specific CD8+ T cells that are unique to their pathogen targets. Moreover, with the high-throughput capacity of profiling hundreds of antigens simultaneously, we apply TetTCR-SeqHD to identify antigens that preferentially enrich cognate CD8+ T cells in patients with type 1 diabetes compared to healthy controls and discover a TCR that cross-reacts with diabetes-related and microbiome antigens. TetTCR-SeqHD is a powerful approach for profiling T cell responses in humans and mice.

DOI: 10.1038/s41590-021-01073-2

Source: https://www.nature.com/articles/s41590-021-01073-2

期刊信息

Nature Immunology:《自然—免疫学》,创刊于2000年。隶属于施普林格·自然出版集团,最新IF:23.53
官方网址:https://www.nature.com/ni/
投稿链接:https://mts-ni.nature.com/cgi-bin/main.plex